Address And Details

PO Box 8009 , Boston, MA 02266
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The Lifecycle 2030 Fund seeks high total return over time through a Combination of capital appreciation and income. The Fund is a fund of funds that invests in Class W shares of other funds of The Trust and in other investment pools or investment products, potentially Including other funds advised by the Fund s investment adviser, Teachers Advisors, LLC ( Advisors ), or its affiliates (collectively, the Underlying Funds ). In general, the Fund is designed for investors who have an approximate target Retirement year in mind, and the Fund s investments are adjusted from more Aggressive to more conservative over time as the Fund s target retirement year Approaches and for approximately 30 years afterwards. The Fund invests in Underlying Funds according to an asset allocation strategy designed for investors Retiring in, or planning to retire within a few years of, 2030 and who may begin Taking systematic withdrawals upon retirement.

Net Asset Value

as of 6:20 PM ET 09/17/2021

Performance

  • 1 Week
  • -0.49%
  • 1 Month
  • +0.58%
  • 3 Months
  • +2.09%
  • 1 Yr Return
  • +12.62%
  • 5 Yr Return
  • +23.91%

Equity Sector Breakdown

Finance 99.80%
ConsumerDurables n/a
Energy n/a
Health n/a
IndustrialCyclical n/a
NonDurables n/a
RetailTrade n/a
Services n/a
Technology n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Other 99.80%
Stocks 0.20%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 369.69 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -1.89 -1.33 -1.87
Beta 0.71 0.70 0.76
R Squared 0.96 0.94 0.93
Std Deviation 13.40 10.76 10.57
Sharpe Ratio 0.81 1.00 n/a

Purchase Information

as of 6:00 PM ET 09/16/2021
Minimum Initial $0
Minimum Additional $0
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +19.68%
  • +26.82%
+19.68% +26.82%
3 Year
  • +11.06%
  • +11.37%
+11.06% +11.37%
10 Year
  • +10.41%
  • +9.32%
+10.41% +9.32%
Life Of Fund
  • +10.04%
  • +9.99%
+10.04% +9.99%

Top 10 Holdings

Symbol Company Name % Of Assets
TIBFX TIAA-CREF BOND PLUS FUND 9.48%
FFEIX NUVEEN DIVIDEND VALUE FUND 6.89%
TCLCX TIAA-CREF LARGE-CAP VALUE 6.87%
TILGX TIAA-CREF LARGE CAP GROWTH 6.63%
TRIHX TIAA-CREF LCAP GROWTH IDX 6.63%
TIIRX TIAA CREF INS GROWTH & INC FD 6.13%
NSBAX NUVEEN STA BARBARA DIV GR FD 6.11%
TIIEX TIAA-CREF INTL EQUITY FUND 5.63%
NBQIX NUVEEN INTERNATIONAL GROWTH F 4.05%
TIOIX TIAA-CREF INTERNATIONAL OPPS 4.03%

Recent Articles from TheStreet

9/11 Lead

Cramer’s Recollections of 9/11

A beautiful day in New York City, Then the Unimaginable

Hong Kong Stocks Slump On Tech Sector Worries As US Official Signals Flaws In China Trade Deal

Intraday Reversals Signal Struggles for Market

But James "Rev Shark" Deporre says the trading action is both normal, and appropriate for September, and he's been adding some names to his portfolio.

stocks market index sh

Cramer's Mad Money Recap: FedEx, Costco, Nike

Jim Cramer says this is a rough season for stock, and investors need to take defensive action.

anxiety grocery mask sh

Jensen: Economy Has a Bearish Outlook

Real Money's Bret Jensen says a slower-than-expected pandemic recovery is a warning for the stock market.

Pfizer vaccine Lead

FDA Panel Recommends Covid Booster Shots for 65, Older and Those at High Risk

Food and Drug Administration's advisory panel on Friday voted to recommend Covid-19 booster shots of the Pfizer vaccine for a limited section of the population.

Ford Lead

Stock Market Today With Jim Cramer: How to Trade Ford

Jim Cramer discusses Ford and the impact of the impending tax policy changes on the stock market.

Jim Cramer: Stay Long Thermo Fisher, Sell FEI

Thermo Fisher Climbs on Strong 2022 Guidance

Thermo Fisher expects revenue to increase 12% year over year next year to $40.3 billion.